Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Spectrum Pharma Inc (SPPI)

Spectrum Pharma Inc (SPPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Watch for Spectrum Pharmac to Potentially Rebound After Falling 1.03% Yesterday

Spectrum Pharmac (NASDAQ:SPPI) traded in a range yesterday that spanned from a low of $8.50 to a high of $8.94. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $9.87...

SPPI : 8.36 (-3.91%)
Why Is Spectrum Pharma (SPPI) Up 23.9% Since Last Earnings Report?

Spectrum Pharma (SPPI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SPPI : 8.36 (-3.91%)
Will Spectrum Pharmaceuticals Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Spectrum Pharmaceuticals.

SPPI : 8.36 (-3.91%)
Watch for Spectrum Pharmac to Potentially Pullback After Gaining 5.70% Yesterday

Spectrum Pharmac (NASDAQ:SPPI) traded in a range yesterday that spanned from a low of $9.18 to a high of $9.33. Yesterday, the shares gained 5.7%, which took the trading range above the 3-day high of...

SPPI : 8.36 (-3.91%)
Options Traders Expect Huge Moves in Spectrum Pharmaceuticals (SPPI) Stock

Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.

SPPI : 8.36 (-3.91%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Cytomx Therapeut (CTMX , SPPI , KPTI , CYTK , ALNY )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CTMX : 7.16 (+0.56%)
KPTI : 16.75 (-1.50%)
SPPI : 8.36 (-3.91%)
Spectrum Pharmac Rises 6.79% on Heavy Volume: Watch For Potential Pullback

Spectrum Pharmac (NASDAQ:SPPI) traded in a range yesterday that spanned from a low of $8.40 to a high of $9.14. Yesterday, the shares gained 6.8%, which took the trading range above the 3-day high of...

SPPI : 8.36 (-3.91%)
Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2019 London Healthcare Conference on November 21st

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that an overview of the company's business strategy and development-stage...

SPPI : 8.36 (-3.91%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Invitae Corp (NVTA , SGMO , SPPI , REGN , SGEN )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

NVTA : 17.16 (+0.76%)
SGMO : 8.51 (-1.96%)
SPPI : 8.36 (-3.91%)
Spectrum Pharmac Set to Possibly Pullback After Yesterday's Rally of 12.11%

Spectrum Pharmac (NASDAQ:SPPI) traded in a range yesterday that spanned from a low of $8.02 to a high of $8.93. Yesterday, the shares gained 12.1%, which took the trading range above the 3-day high of...

SPPI : 8.36 (-3.91%)
Spectrum Pharma's (SPPI) Q3 Loss Narrows, Focus on Rolontis

Spectrum Pharma (SPPI) posts a narrower-than-expected loss for the third quarter of 2019.

ALKS : 20.87 (-1.79%)
AVEO : 0.67 (-4.18%)
ANIK : 53.15 (-0.65%)
SPPI : 8.36 (-3.91%)
Spectrum Pharma: 3Q Earnings Snapshot

HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Thursday reported a loss of $26 million in its third quarter.

SPPI : 8.36 (-3.91%)
Spectrum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Pipeline Update

--Basket trial initiated to study poziotinib in patients with EGFR or HER2 mutation-positive malignant solid tumors in an investigator-led study at The University of Texas MD Anderson Cancer Center

SPPI : 8.36 (-3.91%)
Spectrum Pharmaceuticals Announces Third Quarter 2019 Financial Results Conference Call

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today it will host a conference call with management to discuss the third...

SPPI : 8.36 (-3.91%)
Spectrum Pharmaceuticals Announces Submission to the U.S. Food and Drug Administration of Updated Biologics License Application for ROLONTIS(R)

--ROLONTIS is a novel, long-acting granulocyte colony-stimulating factor (G-CSF) seeking an indication for the treatment of neutropenia in patients receiving myelosuppressive anti-cancer drugs.

SPPI : 8.36 (-3.91%)
Is the Options Market Predicting a Spike in Spectrum Pharma (SPPI) Stock?

Investors need to pay close attention to Spectrum Pharma (SPPI) stock based on the movements in the options market lately.

SPPI : 8.36 (-3.91%)
Spectrum Pharmaceuticals Announces Publication of Positive Poziotinib Data in Cancer Cell

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today a publication from The University of Texas, MD Anderson Cancer...

SPPI : 8.36 (-3.91%)
FibroGen Begins Study on Roxadustat for Chemo-Induced Anemia

FibroGen (FGEN) doses the first patient in a phase II study on roxadustat for the treatment of anemia in cancer patients receiving chemotherapy.

AZN : 48.36 (+0.92%)
SPPI : 8.36 (-3.91%)
FGEN : 46.69 (-1.99%)
VRCA : 14.77 (+1.03%)
Spectrum Pharmac is Among the Companies in the Biotechnology Industry with the Best Relative Performance (SPPI , VNDA , MNTA , ESPR , CHRS )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

MNTA : 16.72 (-0.65%)
SPPI : 8.36 (-3.91%)
VNDA : 16.73 (-1.47%)
Spectrum Pharmaceuticals to Present Corporate Update at the 2019 Cantor Global Healthcare Conference on October 2nd

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that an overview of the company's business strategy and development-stage...

SPPI : 8.36 (-3.91%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.68 , AIZ -0.29 , SBAC +7.43 , SO +0.05 , WELL -0.46
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar